Real-world experience of niraparib as maintenance therapy in newly diagnosed advanced ovarian cancer: A singlecenter retrospective study

被引：0
|
作者：
Wenxin, L. [1 ]
Wang, K. [1 ]
Zhang, L. [1 ]
Ma, Y. [1 ]
Wu, H. [1 ]
Chen, Y. [1 ]
Bao, L. [1 ]
Fu, X. [1 ]
机构：
[1] TMUCIH Tianjin Med Univ Canc Inst & Hosp, Dept Gynecol Oncol, Tianjin, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.436
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315P
引用
收藏
页码：S1594 / S1594
页数：1
相关论文
共 50 条
  • [1] Real-world treatment of niraparib as maintenance therapy in patients newly diagnosed advanced ovarian cancer in Japan
    Shimada, Muneaki
    Kuwahara, Yuki
    Kuwabara, Hiroyo
    Kato, Ai
    Tabata, Tsutomu
    ANNALS OF ONCOLOGY, 2023, 34 : S1440 - S1440
  • [2] Real-world Experience of Niraparib in Newly-diagnosed Epithelial Ovarian Cancer
    Shin, Wonkyo
    Noh, Joseph J.
    Baek, Seung Hun
    Kim, Byoung-Gie
    Lim, Myong Cheol
    Park, Sang-Yoon
    ANTICANCER RESEARCH, 2021, 41 (09) : 4603 - 4607
  • [3] RENI-1: a prospective, multicenter real-world study of niraparib as first-line maintenance therapy in newly diagnosed advanced ovarian cancer
    Zuo, Jing
    Wang, Ke
    Cui, Zhumei
    Li, Qingshui
    Cheng, Xiaodong
    Zheng, Zhong
    Sun, Lixin
    Zhang, Hui
    Zhang, Jun
    Wang, Shuhe
    Cao, Dongyan
    Chen, Lihong
    Zhao, Hongqin
    Duan, Wei
    Zheng, Min
    Shou, Huafeng
    Li, Jin
    Wang, Yue
    Chen, Xiaoxiang
    Wu, Lingying
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A315 - A315
  • [4] Real-world adverse events with niraparib 200 mg/day maintenance therapy in ovarian cancer: a retrospective study
    Gallagher, Jack R.
    Heap, Kylee Jean
    Carroll, Susan
    Travers, Karin
    Harrow, Brooke
    Westin, Shannon N.
    FUTURE ONCOLOGY, 2019, 15 (36) : 4197 - 4206
  • [5] Starting dose of niraparib as first-line maintenance among patients with newly diagnosed advanced ovarian cancer in a real-world database
    Liu, Jinan
    Thaker, Premal
    Song, Jinlin
    Kalilani, Linda
    Guo, Helen
    Wu, Eric
    Hurteau, Jean
    Chan, John
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S180 - S180
  • [6] Niraparib maintenance in newly diagnosed advanced ovarian cancer - review and case series
    Tyszka, Martyna
    Stec, Rafal
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (06): : 413 - 418
  • [7] Real-world experience with a first-line niraparib maintenance monotherapy for advanced ovarian carcinoma
    Gregoric, Brigita
    Skof, Erik
    Skrbinc, Breda
    Geltar, Ana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A220 - A220
  • [8] FIRST REAL-WORLD HEMATOLOGIC ADVERSE EVENTS EXPERIENCE WITH NIRAPARIB IN ADVANCED OVARIAN CANCER
    Wang, Junjian
    Zhu, Jianqing
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A79 - A80
  • [9] Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
    Gonzalez-Martin, A.
    Pothuri, B.
    Vergote, I.
    DePont Christensen, R.
    Graybill, W.
    Mirza, M. R.
    McCormick, C.
    Lorusso, D.
    Hoskins, P.
    Freyer, G.
    Baumann, K.
    Jardon, K.
    Redondo, A.
    Moore, R. G.
    Vulsteke, C.
    O'Cearbhaill, R. E.
    Lund, B.
    Backes, F.
    Barretina-Ginesta, P.
    Haggerty, A. F.
    Rubio-Perez, M. J.
    Shahin, M. S.
    Mangili, G.
    Bradley, W. H.
    Bruchim, I.
    Sun, K.
    Malinowska, I. A.
    Li, Y.
    Gupta, D.
    Monk, B. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2391 - 2402
  • [10] Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer
    Van Le, Linda
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2020, 75 (01) : 29 - 31
12345